Nephros (NEPH) Other financing activities (2011 - 2026)

Nephros (NEPH) posted Other financing activities of $290000.0 for Q1 2026, up 54.26% on a QoQ basis from $188000.0 in Q1 2022.

Analysis

Nephros (NEPH) Other financing activities (2011 - 2026) Analysis & Trends

Nephros has reported Other financing activities for 11 years, with the latest figure at $290000.0 in Q1 2026.

On a quarterly basis, Other financing activities changed N/A year-over-year to $290000.0 in Q1 2026; TTM through Jun 2026 was $290000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $188000.0, down 36.7% from the prior year.
Other financing activities was $290000.0 for Q1 2026 at Nephros, up from $188000.0 in the prior quarter.
The five-year high for Other financing activities was $290000.0 in Q1 2026, with the low at $188000.0 in Q1 2022.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	178.01 Bn	172.41 Bn	7.27 Bn
2	Intuitive Surgical	131.29 Bn	126.08 Bn	1.96 Bn
3	Medtronic	116.38 Bn	107.56 Bn	6.34 Bn
4	Stryker	106.01 Bn	102.53 Bn	4.50 Bn
5	Boston Scientific	63.40 Bn	62.86 Bn	3.85 Bn
6	Edwards Lifesciences	48.89 Bn	44.64 Bn	1.35 Bn
7	Alcon	32.59 Bn	31.13 Bn	1.68 Bn
8	Dexcom	31.84 Bn	29.89 Bn	830.00 Mn
9	Steris	20.61 Bn	20.13 Bn	684.20 Mn
10	Nephros	48.31 Mn	43.62 Mn	4.03 Mn

Historic Data

Download Data